Genetics and imaging of hepatocellular adenomas: 2011 update.
暂无分享,去创建一个
[1] M. Ronot,et al. Hepatocellular adenomas: Accuracy of magnetic resonance imaging and liver biopsy in subtype classification , 2011, Hepatology.
[2] V. Paradis,et al. Changing trends in malignant transformation of hepatocellular adenoma , 2010, Gut.
[3] J. Zucman‐Rossi,et al. Subtype Classification of Hepatocellular Adenoma , 2010, Digestive Surgery.
[4] J. Zucman‐Rossi,et al. 561 CONTRAST-ENHANCED ULTRA SONOGRAPHY TO IDENTIFY THE TWO MAJOR SUBTYPES OF HEPATOCELLULAR ADENOMA , 2010 .
[5] O. Farges,et al. Malignant Transformation of Liver Adenoma: An Analysis of the Literature , 2010, Digestive Surgery.
[6] V. Paradis,et al. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. , 2009, Gastroenterology.
[7] J. Ijzermans,et al. Hepatocellular adenoma: cost-effectiveness of different treatment strategies. , 2009, Radiology.
[8] J. Zucman‐Rossi,et al. Hepatocellular adenoma management and phenotypic classification: The Bordeaux experience , 2009, Hepatology.
[9] C. Trautwein,et al. Frequent in‐frame somatic deletions activate gp130 in inflammatory hepatocellular tumors , 2009, Hepatology.
[10] S. Imbeaud,et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours , 2009, Nature.
[11] Paulette Bioulac-Sage,et al. Hepatocellular adenomas , 2009, Liver international : official journal of the International Association for the Study of the Liver.
[12] Yutaka Takigawa,et al. Wnt signaling in liver cancer. , 2008, Current drug targets.
[13] H. Rhim,et al. Radiofrequency ablation of hepatic tumors: Lessons learned from 3000 procedures , 2008, Journal of gastroenterology and hepatology.
[14] J. Zucman‐Rossi,et al. Hepatocellular adenomas: Magnetic resonance imaging features as a function of molecular pathological classification , 2008, Hepatology.
[15] J. Zucman‐Rossi,et al. Hepatocellular adenoma: what is new in 2008 , 2008, Hepatology international.
[16] D. Gouma,et al. Liver adenomatosis: re‐evaluation of aetiology and management , 2008, Liver international : official journal of the International Association for the Study of the Liver.
[17] Cristel G. Thomas,et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry , 2007, Hepatology.
[18] M. Ronot,et al. Telangiectatic adenoma: An entity associated with increased body mass index and inflammation , 2007, Hepatology.
[19] J. Zucman‐Rossi,et al. Genotype phenotype classification of hepatocellular adenoma. , 2007, World journal of gastroenterology.
[20] C. Auffray,et al. HNF1α Inactivation Promotes Lipogenesis in Human Hepatocellular Adenoma Independently of SREBP-1 and Carbohydrate-response Element-binding Protein (ChREBP) Activation* , 2007, Journal of Biological Chemistry.
[21] S. Monga,et al. WNT/β‐catenin signaling in liver health and disease , 2007 .
[22] V. Paradis,et al. Liver adenomatosis: classification of MR imaging features and comparison with pathologic findings. , 2006, Radiology.
[23] V. Huurman,et al. Necrosis of a large hepatic tumor after hemorrhage and subsequent selective arterial embolization. , 2006, World journal of gastroenterology.
[24] D. Gouma,et al. Management of spontaneous haemorrhage and rupture of hepatocellular adenomas. A single centre experience , 2006, Liver international : official journal of the International Association for the Study of the Liver.
[25] J. Zucman‐Rossi,et al. Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC , 2006, Hepatology.
[26] J. Zucman‐Rossi,et al. Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. , 2005, Gastroenterology.
[27] J. Charboneau,et al. Successful treatment of hepatocellular adenoma with percutaneous radiofrequency ablation. , 2005, AJR. American journal of roentgenology.
[28] William D Middleton,et al. Fat-containing lesions of the liver: radiologic-pathologic correlation. , 2005, Radiographics : a review publication of the Radiological Society of North America, Inc.
[29] J. Zucman‐Rossi,et al. Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. , 2003, Gastroenterology.
[30] J. Van Damme,et al. The CC chemokine CCL20 and its receptor CCR6. , 2003, Cytokine & growth factor reviews.
[31] M. Buendia. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects. , 2002, Medical and pediatric oncology.
[32] Y. Jeng,et al. p53 gene and Wnt signaling in benign neoplasms: β‐catenin mutations in hepatic adenoma but not in focal nodular hyperplasia , 2002, Hepatology.
[33] J. Zucman‐Rossi,et al. Bi-allelic inactivation of TCF1 in hepatic adenomas , 2002, Nature Genetics.
[34] T. Ichikawa,et al. Hepatic adenomas: imaging and pathologic findings. , 2001, Radiographics : a review publication of the Radiological Society of North America, Inc.
[35] T. Ichikawa,et al. Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients. , 2000, Radiology.
[36] J. Liehr,et al. Estrogens as endogenous genotoxic agents--DNA adducts and mutations. , 2000, Journal of the National Cancer Institute. Monographs.
[37] T. Ichikawa,et al. Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. , 2000, Radiology.
[38] G. Gores,et al. Management of liver adenomatosis: results with a conservative surgical approach. , 1998, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[39] C. Degott,et al. Liver adenomatosis. An entity distinct from liver adenoma? , 1985, Gastroenterology.
[40] B. Henderson,et al. Liver-cell adenomas associated with use of oral contraceptives. , 1976, The New England journal of medicine.
[41] Wesley O C Greaves,et al. Hepatic adenomatosis. , 2008, Archives of pathology & laboratory medicine.
[42] S. Monga,et al. WNT/beta-catenin signaling in liver health and disease. , 2007, Hepatology.
[43] M. Wolverson,et al. Benign hepatocellular tumors (adenomatosis) in nonalcoholic steatohepatitis: a case report. , 2005, Seminars in liver disease.
[44] S. Ellard. Hepatocyte nuclear factor 1 alpha (HNF-1 alpha) mutations in maturity-onset diabetes of the young. , 2000, Human mutation.
[45] J. Grosgeorge,et al. Human gp130 transducer chain gene (IL6ST) is localized to chromosome band 5q11 and possesses a pseudogene on chromosome band 17p11. , 1995, Cytogenetics and cell genetics.